The forecast for hospital discharges for hyperplasia of prostate in France suggests a continuous decline from 2024 to 2028. In 2023, the value stood at 123.5 discharges per hundred thousand persons. From 2024 to 2025, there is a decrease of approximately 2.1%. Further declines occur with decreases of around 2% in both 2026 and 2027, and a 1.9% decrease in 2028. The compound annual growth rate (CAGR) over these five years is indicative of a consistent downward trend.
Future trends to watch for include advancements in medical treatments that may reduce the necessity for hospital discharges, as well as demographic changes that can impact the prevalence of prostate hyperplasia. Monitoring these factors can provide insights into the healthcare demand in the context of prostate conditions.
